Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on CELGENE CORPORATION
10/26/17 | 01:30pm Q3 2017 Earnings Release
10/26/17 | 03:00pm Q3 2017 Earnings Call
10/28/17 | 06:00pm American Committee for Treatment and Research in Multiple Sclerosis Meeting
01/25/18 FY 2017 Earnings Release (Projected)
Past events on CELGENE CORPORATION
09/26/17 | 03:45pm Cantor Fitzgerald Global Healthcare Conference
09/14/17 | 05:10pm Bank of America Merrill Lynch Global Health Care Conference
09/13/17 | 03:20pm Morgan Stanley Global Healthcare Conference
09/11/17 | 04:30pm European Society for Medical Oncology Congress - Abstract 622PD
Upcoming sector events for CELGENE CORPORATION
10/17/17 MERCK & CO., INC. : BIO Investor Forum
10/17/17 | 02:30am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #P2.07-027
10/17/17 | 06:00am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #P2.01-012
10/17/17 | 02:30pm JOHNSON & JOHNSON : Q3 2017 Earnings Call
Past sector events for CELGENE CORPORATION
10/16/17 | 02:30am MERCK & CO., INC. : International Association for the Study of Lung Cancer World Conference - Abstract P1.01-050
10/16/17 | 02:30am BRISTOL-MYERS SQUIBB CO : International Association for the Study of Lung Cancer World Conference - Abstract #P1.15-003
10/16/17 | 02:30am TAKEDA PHARMACEUTICAL CO LTD : International Association for the Study of Lung Cancer Conference - Abstract 8346
10/16/17 | 04:05am MERCK & CO., INC. : International Association for the Study of Lung Cancer World Conference - Abstract MA 02.02
Annual publications
Previous yearNext Year
Annual results2014201520162017 (e)2018 (e)
Sales
Million $
Released
Forecast
Spread
7 670
7 663
0,10%
9 256
9 238
0,19%
11 229
11 271
-0,37%

13 248

15 455
Operating income (EBITDA)
Million $
Released
Forecast
Spread
3 986
4 188
-4,8%
4 942
5 097
-3,0%
6 298
6 656
-5,4%

8 152

9 303
Operating profit (EBIT)
Million $
Released
Forecast
Spread
3 881
3 733
4,0%
4 812
4 678
2,9%
6 177
6 152
0,40%

7 532

8 866
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
2 000
2 024
-1,2%
1 602
1 590
0,73%
1 999
2 435
-18%

4 348

5 702
EPS
 $
Released
Forecast
Spread
2,39
2,43
-1,6%
1,94
1,97
-1,3%
2,49
2,99
-17%

5,64

7,31
Announcement Date01/29/201501/28/201601/26/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ4
2016
Q1
2017
Q2
2017
Q3
2017 (e)
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
2 981
3 017
-1,2%
2 960
3 039
-2,6%
3 268
3 231
1,1%

3 430

3 590
Operating income (EBITDA)
Million $
Released
Forecast
Spread
1 701
1 646
3,4%
1 752
1 679
4,3%
1 977
1 841
7,4%

1 957

2 160
Operating profit (EBIT)
Million $
Released
Forecast
Spread
1 668
1 645
1,4%
1 720
1 676
2,6%
1 943
1 822
6,7%

1 918

2 004
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
429
863
-50%
941
939
0,24%
1 061
1 146
-7,4%

1 116

1 289
EPS
 $
Released
Forecast
Spread
0,53
0,98
-46%
1,16
1,22
-5,1%
1,31
1,36
-3,8%

1,43

1,64
Announcement Date01/26/201704/27/201707/27/2017

© 2017 Thomson Reuters
© 2017 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise